Request Demo
Last update 08 May 2025
Shanghai Kangdai Biomedical Technology Co., Ltd.
Last update 08 May 2025
Overview
Basic Info
Introduction Shanghai Kanda Biotechnology Co., Ltd. is a leading company in the field of biotechnology, specializing in research, development, production and sales of high-tech bio-products. With a strong R&D team and advanced production facilities, Kanda Biotechnology has achieved many outstanding achievements in the field of biotechnology and is committed to providing customers with quality products and services. |
Related
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
CTR20234285
KD6005 注射液在中国健康成年受试者及类风湿关节炎患者中的安全性、耐受性、药代动力学及初步药效学的随机、双盲、安慰剂对照的 I期临床研究
[Translation] A randomized, double-blind, placebo-controlled Phase I clinical study of the safety, tolerability, pharmacokinetics and preliminary pharmacodynamics of KD6005 injection in healthy Chinese adults and patients with rheumatoid arthritis
CTR20230746
一项评价 KD6001 注射液联合特瑞普利单抗在晚期黑色素瘤患者中安全性、耐受性、药代动力学和初步疗效的临床研究
[Translation] A clinical study to evaluate the safety, tolerability, pharmacokinetics and preliminary efficacy of KD6001 injection combined with toripalimab in patients with advanced melanoma
NCT05230290
Evaluation of Safety, Tolerability, and Pharmacokinetics of KD6001 in Patients With Advanced Solid Tumours - Phase I Clinical Study
100 Clinical Results associated with Shanghai Kangdai Biomedical Technology Co., Ltd.
Login to view more data
Login to view more data
100 Deals associated with Shanghai Kangdai Biomedical Technology Co., Ltd.
Login to view more data
100 Translational Medicine associated with Shanghai Kangdai Biomedical Technology Co., Ltd.
Login to view more data
Corporation Tree
Boost your research with our corporation tree data.
login
or
Pipeline
Pipeline Snapshot as of 04 Aug 2025
The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
IND Approval
2
Login to view more data
Current Projects
Login to view more data
Deal
Boost your decision using our deal data.
login
or
Translational Medicine
Boost your research with our translational medicine data.
login
or
Profit
Explore the financial positions of over 360K organizations with Synapse.
login
or
Grant & Funding(NIH)
Access more than 2 million grant and funding information to elevate your research journey.
login
or
Investment
Gain insights on the latest company investments from start-ups to established corporations.
login
or
Financing
Unearth financing trends to validate and advance investment opportunities.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free